Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9139875rdf:typepubmed:Citationlld:pubmed
pubmed-article:9139875lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9139875lifeskim:mentionsumls-concept:C1513095lld:lifeskim
pubmed-article:9139875lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:9139875lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:9139875lifeskim:mentionsumls-concept:C0030943lld:lifeskim
pubmed-article:9139875lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:9139875lifeskim:mentionsumls-concept:C0752681lld:lifeskim
pubmed-article:9139875pubmed:issue3lld:pubmed
pubmed-article:9139875pubmed:dateCreated1997-5-29lld:pubmed
pubmed-article:9139875pubmed:abstractTextThe oncogenic potential of translation initiation factors (eIF-4E and eIF-2alpha) has been described in previous studies leading to the definition of translational oncogenes. Two previously isolated cDNA clones, expressed differently in human melanoma cells and normal human melanocytes, were identified in this study as coding for the translation initiation factor eIF-4A1. Northern-blot analysis revealed consistent overexpression of eIF-4A1 mRNA in a panel of 14 melanoma cell lines (on an average 5.6 times higher than in cultures of normal human melanocytes). In contrast, the mRNAs of the other group-4 translation initiation factors (eIF-4A2, eIF-4B, eIF-4E and eIF-4gamma) were less and not consistently elevated. Cultures of congenital melanocytic nevi exhibited intermediate expression of eIF-4A1. Thus, eIF-4A1 overexpression seems to be an important feature of melanoma cells and might contribute to their malignant transformation.lld:pubmed
pubmed-article:9139875pubmed:languageenglld:pubmed
pubmed-article:9139875pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139875pubmed:citationSubsetIMlld:pubmed
pubmed-article:9139875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139875pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9139875pubmed:statusMEDLINElld:pubmed
pubmed-article:9139875pubmed:monthMaylld:pubmed
pubmed-article:9139875pubmed:issn0020-7136lld:pubmed
pubmed-article:9139875pubmed:authorpubmed-author:OrfanosC ECElld:pubmed
pubmed-article:9139875pubmed:authorpubmed-author:EberleJJlld:pubmed
pubmed-article:9139875pubmed:authorpubmed-author:KrasagakisKKlld:pubmed
pubmed-article:9139875pubmed:issnTypePrintlld:pubmed
pubmed-article:9139875pubmed:day2lld:pubmed
pubmed-article:9139875pubmed:volume71lld:pubmed
pubmed-article:9139875pubmed:ownerNLMlld:pubmed
pubmed-article:9139875pubmed:authorsCompleteYlld:pubmed
pubmed-article:9139875pubmed:pagination396-401lld:pubmed
pubmed-article:9139875pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:meshHeadingpubmed-meshheading:9139875-...lld:pubmed
pubmed-article:9139875pubmed:year1997lld:pubmed
pubmed-article:9139875pubmed:articleTitleTranslation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro.lld:pubmed
pubmed-article:9139875pubmed:affiliationDepartment of Dermatology, Benjamin Franklin University Medical Center, The Free University of Berlin, Germany.lld:pubmed
pubmed-article:9139875pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9139875pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1981entrezgene:pubmedpubmed-article:9139875lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9139875lld:pubmed